by iitri | Aug 11, 2017 | News
IITRI now has expanded animal biosafety level 3 (ABSL-3) capacity to conduct pathogen challenge studies for vaccines or therapeutics in non-human primates (NHPs). Our ABSL-3 laboratories include head-only aerosol infection by inhalation exposure and plethysmography...
by iitri | Jul 25, 2017 | News
A mouse pregnancy model is now available from IITRI to evaluate the ability of vaccines or antivirals for protection against Zika virus (ZIKV) maternal-fetal viral transmission and resulting fetal defects such as microcephaly. Details of this mouse model and its use...
by iitri | Jul 17, 2017 | News
IITRI is pleased to announce the addition of immunophenotyping services using flow cytometry to our ex vivo assay offerings. In flow cytometry, multiple properties can be analyzed simultaneously at the single cell level by generating a stream of cells in single-file...
by iitri | May 2, 2017 | News
IITRI is pleased to announce the expansion of our infectious disease immunology capabilities with the recent hiring of Justin Richner, PhD, to the position of Research Biologist, Viral Immunology. Dr. Richner’s research focus includes viral pathogenesis and host...
by iitri | Mar 31, 2017 | News
IITRI was one of 7 organizations chosen as a member of a Nonclinical Studies Network created by BARDA to aid in the successful development of medical countermeasures for biological threats. Nonclinical studies supporting treatments for biological threats is especially...
by iitri | Oct 3, 2016 | News
IITRI will be presenting at the upcoming International Meeting on Emerging Diseases and Surveillance (IMED) November 4-7, 2016 in Vienna, Austria, on Zika Mouse and Macque Models developed by our Molecular and Microbiology team. For more details, please contact us....
Recent Comments